Hypothesis for Potential Pathogenesis of SARS-CoV-2 Infection-a Review of Immune Changes in Patients with Viral Pneumonia

Overview

Journal Emerg Microbes Infect

Specialty Infectious Diseases

Date 2020 Mar 21

PMID 32196410

Citations 430

Authors

Ling Lin

Lianfeng Lu

Wei Cao

Taisheng Li

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with droplets and contact as the main means of transmission. Since the first case appeared in Wuhan, China, in December 2019, the outbreak has gradually spread nationwide. Up to now, according to official data released by the Chinese health commission, the number of newly diagnosed patients has been declining, and the epidemic is gradually being controlled. Although most patients have mild symptoms and good prognosis after infection, some patients developed severe and die from multiple organ complications. The pathogenesis of SARS-CoV-2 infection in humans remains unclear. Immune function is a strong defense against invasive pathogens and there is currently no specific antiviral drug against the virus. This article reviews the immunological changes of coronaviruses like SARS, MERS and other viral pneumonia similar to SARS-CoV-2. Combined with the published literature, the potential pathogenesis of COVID-19 is inferred, and the treatment recommendations for giving high-doses intravenous immunoglobulin and low-molecular-weight heparin anticoagulant therapy to severe type patients are proposed.

Citing Articles

The impact of long COVID on heart rate variability: a cross-sectional study.

Qin M, Lee K, Yoo S BMC Infect Dis. 2025; 25(1):261.

PMID: 39994668 PMC: 11849358. DOI: 10.1186/s12879-024-10361-9.

SARS-CoV-2 Infection and Alpha-Synucleinopathies: Potential Links and Underlying Mechanisms.

Motyl J, Gromadzka G, Czapski G, Adamczyk A Int J Mol Sci. 2024; 25(22).

PMID: 39596147 PMC: 11593367. DOI: 10.3390/ijms252212079.

Immunity and Coagulation in COVID-19.

Avdonin P, Blinova M, Serkova A, Komleva L, Avdonin P Int J Mol Sci. 2024; 25(20).

PMID: 39457048 PMC: 11508857. DOI: 10.3390/ijms252011267.

Dynamic Characteristics of Lymphocyte Subsets and Their Predictive Value for Disease Progression and Prognosis in Primary Infection and Unvaccinated COVID-19 Patients.

Zhang X, Chen Z, Zheng J, Feng C, Zhao B, Lan L Int J Gen Med. 2024; 17:4559-4577.

PMID: 39403609 PMC: 11472736. DOI: 10.2147/IJGM.S478912.

Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes.

Kang S, Eather G, Qureshi F, Scott J IJTLD Open. 2024; 1(10):443-448.

PMID: 39398431 PMC: 11467851. DOI: 10.5588/ijtldopen.24.0180.

References

Yu F, Du L, Ojcius D, Pan C, Jiang S . Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes Infect. 2020; 22(2):74-79. PMC: 7102556. DOI: 10.1016/j.micinf.2020.01.003. View

Letko M, Marzi A, Munster V . Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020; 5(4):562-569. PMC: 7095430. DOI: 10.1038/s41564-020-0688-y. View

Mohn K, Cox R, Tunheim G, Berdal J, Hauge A, Jul-Larsen A . Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway. PLoS One. 2015; 10(11):e0143281. PMC: 4659565. DOI: 10.1371/journal.pone.0143281. View

Ho J, Wu A, Lam B, Ooi G, Khong P, Ho P . Pentaglobin in steroid-resistant severe acute respiratory syndrome. Int J Tuberc Lung Dis. 2004; 8(10):1173-9. View

Zhong N, Zheng B, Li Y, Poon , Xie Z, Chan K . Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet. 2003; 362(9393):1353-8. PMC: 7112415. DOI: 10.1016/s0140-6736(03)14630-2. View

Saad M, Omrani A, Baig K, Bahloul A, Elzein F, Matin M . Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014; 29:301-6. PMC: 7110769. DOI: 10.1016/j.ijid.2014.09.003. View

Ko J, Park G, Lee J, Lee J, Cho S, Ha Y . Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients. J Infect. 2016; 73(5):468-475. PMC: 7112644. DOI: 10.1016/j.jinf.2016.08.005. View

Munster V, de Wit E, van den Brand J, Herfst S, Schrauwen E, Bestebroer T . Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science. 2009; 325(5939):481-3. PMC: 4814155. DOI: 10.1126/science.1177127. View

de Wit E, Rasmussen A, Falzarano D, Bushmaker T, Feldmann F, Brining D . Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A. 2013; 110(41):16598-603. PMC: 3799368. DOI: 10.1073/pnas.1310744110. View

10.

Guan W, Mok C, Chen Z, Feng L, Li Z, Huang J . Characteristics of Traveler with Middle East Respiratory Syndrome, China, 2015. Emerg Infect Dis. 2015; 21(12):2278-80. PMC: 4672405. DOI: 10.3201/eid2112.151232. View

11.

Harmer D, Gilbert M, Borman R, Clark K . Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme. FEBS Lett. 2002; 532(1-2):107-10. DOI: 10.1016/s0014-5793(02)03640-2. View

12.

Wilkinson T, Li C, Chui C, Huang A, Perkins M, Liebner J . Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012; 18(2):274-80. DOI: 10.1038/nm.2612. View

13.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

14.

Min C, Cheon S, Ha N, Sohn K, Kim Y, Aigerim A . Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep. 2016; 6:25359. PMC: 4857172. DOI: 10.1038/srep25359. View

15.

Stockman L, Bellamy R, Garner P . SARS: systematic review of treatment effects. PLoS Med. 2006; 3(9):e343. PMC: 1564166. DOI: 10.1371/journal.pmed.0030343. View

16.

Juarez-Reyes A, Noyola D, Monsivais-Urenda A, Alvarez-Quiroga C, Gonzalez-Amaro R . Influenza virus infection but not H1N1 influenza virus immunization is associated with changes in peripheral blood NK cell subset levels. Clin Vaccine Immunol. 2013; 20(8):1291-7. PMC: 3754504. DOI: 10.1128/CVI.00194-13. View

17.

Zhao J, Alshukairi A, Baharoon S, Ahmed W, Bokhari A, Nehdi A . Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses. Sci Immunol. 2017; 2(14). PMC: 5576145. DOI: 10.1126/sciimmunol.aan5393. View

18.

Zaki A, van Boheemen S, Bestebroer T, Osterhaus A, Fouchier R . Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367(19):1814-20. DOI: 10.1056/NEJMoa1211721. View

19.

Li W, Moore M, Vasilieva N, Sui J, Wong S, Berne M . Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003; 426(6965):450-4. PMC: 7095016. DOI: 10.1038/nature02145. View

20.

Bermejo-Martin J, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P . Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care. 2009; 13(6):R201. PMC: 2811892. DOI: 10.1186/cc8208. View